Sharma falls ill. Let the UK's world beating test and trace system kick in, and do it's world beating business of contacting those he was in contact with, and informing them to isolate. Given that it was yesterday they should all be isolating my now. I wonder who will do the daily Jackanory this afternoon?
Current Affairs Coronavirus Thread - Serious stuff !!!
- Thread starter bullybeef
- Start date
- Status
Oh right 'severe hay fever'. The cop out for why Sharma did not self isolating when those in contact with him haven't self isolated. Do as I say, not as I do. The message from the government and 'experts', 'you must self isolate if you have symptoms' but Sharma carried on putting other people's health at risk and not protecting the NHS.
Sharma's illness could be hayfever, not Covid-19, says cabinet colleague Brandon Lewis
The business secretary, Alok Sharma, might have had a bout of “severe hayfever” when he appeared ill in the House of Commons on Wednesday, according to the Northern Ireland secretary, Brandon Lewis.
Speaking to BBC Radio 4’s Today programme, Lewis said: “I don’t want to be premature because Alok, who I wish well and hope he recovers quickly, may well have had severe hayfever, we’re not sure yet.”
He denied that Sharma’s case supported the argument for virtual voting in the Commons to be resumed. He said:
Sharma's illness could be hayfever, not Covid-19, says cabinet colleague Brandon Lewis
The business secretary, Alok Sharma, might have had a bout of “severe hayfever” when he appeared ill in the House of Commons on Wednesday, according to the Northern Ireland secretary, Brandon Lewis.
Speaking to BBC Radio 4’s Today programme, Lewis said: “I don’t want to be premature because Alok, who I wish well and hope he recovers quickly, may well have had severe hayfever, we’re not sure yet.”
He denied that Sharma’s case supported the argument for virtual voting in the Commons to be resumed. He said:
Matt Hancock exhorted the public to do their “civic duty” and stay at home when instructed, as he launched a new test and trace system in the face of warnings from council leaders that they lack the data or powers to make local lockdowns work.
“It is your civic duty,” said Hancock. “This will be voluntary at first because we trust everyone to do the right thing, but we can quickly make it mandatory if that’s what it takes.
“Do it for the people you love. Do it for the community. Do it for the NHS and do it for all the frontline workers who have done so much and gone out every day to put themselves at risk to keep you and your family safe.”
However, this will be the cabinet's response.
“It is your civic duty,” said Hancock. “This will be voluntary at first because we trust everyone to do the right thing, but we can quickly make it mandatory if that’s what it takes.
“Do it for the people you love. Do it for the community. Do it for the NHS and do it for all the frontline workers who have done so much and gone out every day to put themselves at risk to keep you and your family safe.”
However, this will be the cabinet's response.
davek
Player Valuation: £150m
UK population 66M
EU combined population 450M
The UK Banana Republic, run by murdering scum.
WE CANT BREATHE
WE CANT BREATHE
Barnfred 55
Player Valuation: £80m
What are the Tory cabinet doing in Rhodes?
BlueStevie35
Player Valuation: £70m
Spain really shouldn’t be on that side of the bracket considering they mysteriously wiped off 2000 deaths a couple of days ago
lol The landlord paid for it.I ain't FFIN daft lol lol
lol lol lol
peteblue
Welcome back Wayne
It was reported daily on here comparisons with other EU countries, but showing days or weeks behind. We are still days or weeks behind, so it’s not really clever doing a comparison of data on the same day and ignoring the delay......
peteblue
Welcome back Wayne
Plus the other 17k not accounted for. But these are just numbers. It’s good to see their numbers coming down to almost nothing, and in a week or two our numbers will follow.....
Just been sent this:
"Earlier this week the advisor to the NHS’s contact-tracing app efforts, Professor Floridi, said countries relying solely on tech giants for delivering their track and trace solutions could be ceding power to them. Michael Lewis, Professor of Life Science Innovation at the University of Birmingham, and Non-Executive Chairman of iPLATO, the developers of the UK’s leading NHS patient healthcare app ‘myGP’ shares a different perspective.
The comments from Professor Floridi highlight one side of the debate around the state wanting to control patient data and the individuals themselves keeping control of their health data via Google and Apple. The reason the UK is still without a fully functioning track and trace app is due to the NHS’s belief that patient data is their asset, and their subsequent efforts to guard it from the tech moguls. However, by going its own way, the NHS has taken on the mantle of ‘below par’ software development, as we have seen with the NHS App and with the Covid-19 track and trace app.
Putting this simply, Google does not do brain surgery, so why should the NHS build or specify technology? The NHS exists to treat patients - not to build technology, and as a result we are seeing inevitable delays, scope creep, partial solutions, and high costs - and during this time, lives are lost. The NHS track and trace app was originally planned for a mid-May national launch and is still not fit for purpose.
When it comes to the ethical debate around patient data, there is a camp of academics who view this information as belonging to the patient, and not the state. If one is considering the ethics of accessing patient data, then recent activity has shown how simply the state can waive the law to access citizens’ data that is normally protected by GDPR, and immediately our privacy is eroded.
Enabling Google and Apple temporary access to our data, in the interest of our health, or potentially our lives, seems reasonable, especially when there is no guarantee that we can trust the state to guard our data. In reality, anyone online already shares health data with Google and Apple every day, from simple search history to location data and app usage, right through to our purchasing history and our calendars.
With this in mind, as long as there are reasonable parameters in place in terms of how long the tech giants can access patient’s data for, one could say that the data horse has already bolted, and the philosophical debate about who owns what should be put aside in the interest of delivering a functional track and trace technology that can impact a 15-20 percent reduction in Covid-19 transmission, and save lives from day one.
To my knowledge, the actual patients, whose data is being debated, have not been consulted at any stage in this process. With so many mortalities in the UK, one would suggest that many citizens would be more than happy to donate their data to help with vaccine development, therapeutics and helping to reduce transmission, as long as the request to use their data is clear, transparent and time limited.
As the non-executive chairman of iPLATO, the developers of myGP, the free app that enables its 1.7 million NHS patient users to book appointments and access their own medical records as well as monitor and manage their own health, we regularly speak to patients about their user journey, data sharing and privacy constantly. The general consensus amongst patients when it comes to data sharing, is that if a technology acts in the interest of their health and their data is safe, they will use it - and very rarely would the developer of the app play a part in the patient’s decision-making process, further confirming that state, or tech giant - we just need a track and trace app, and quick.
About Professor Michael Lewis
Professor Michael Lewis has 30 years global health industry experience and among other roles is currently Executive Chair of iPlato, the developers of the UK’s leading medical app myGP. He is also Executive Chair of a patient mental health platform with 21 million registered users in the UK, and Chair of Cambridge Cognition plc, the neuro-psychological, diagnostics company.
Previously he held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (New Jersey), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn public to private buyout. After spending 22 of the last 26 years living and working outside the UK, Mike now works with UK based companies.
Mike also Chairs the Assisted Living Innovation Platform, is the Chair of the Biocatalyst Major Awards Panel, Chairs the KTN MedTech Board and acts as healthcare advisor for multiple private equity companies."
"Earlier this week the advisor to the NHS’s contact-tracing app efforts, Professor Floridi, said countries relying solely on tech giants for delivering their track and trace solutions could be ceding power to them. Michael Lewis, Professor of Life Science Innovation at the University of Birmingham, and Non-Executive Chairman of iPLATO, the developers of the UK’s leading NHS patient healthcare app ‘myGP’ shares a different perspective.
The comments from Professor Floridi highlight one side of the debate around the state wanting to control patient data and the individuals themselves keeping control of their health data via Google and Apple. The reason the UK is still without a fully functioning track and trace app is due to the NHS’s belief that patient data is their asset, and their subsequent efforts to guard it from the tech moguls. However, by going its own way, the NHS has taken on the mantle of ‘below par’ software development, as we have seen with the NHS App and with the Covid-19 track and trace app.
Putting this simply, Google does not do brain surgery, so why should the NHS build or specify technology? The NHS exists to treat patients - not to build technology, and as a result we are seeing inevitable delays, scope creep, partial solutions, and high costs - and during this time, lives are lost. The NHS track and trace app was originally planned for a mid-May national launch and is still not fit for purpose.
When it comes to the ethical debate around patient data, there is a camp of academics who view this information as belonging to the patient, and not the state. If one is considering the ethics of accessing patient data, then recent activity has shown how simply the state can waive the law to access citizens’ data that is normally protected by GDPR, and immediately our privacy is eroded.
Enabling Google and Apple temporary access to our data, in the interest of our health, or potentially our lives, seems reasonable, especially when there is no guarantee that we can trust the state to guard our data. In reality, anyone online already shares health data with Google and Apple every day, from simple search history to location data and app usage, right through to our purchasing history and our calendars.
With this in mind, as long as there are reasonable parameters in place in terms of how long the tech giants can access patient’s data for, one could say that the data horse has already bolted, and the philosophical debate about who owns what should be put aside in the interest of delivering a functional track and trace technology that can impact a 15-20 percent reduction in Covid-19 transmission, and save lives from day one.
To my knowledge, the actual patients, whose data is being debated, have not been consulted at any stage in this process. With so many mortalities in the UK, one would suggest that many citizens would be more than happy to donate their data to help with vaccine development, therapeutics and helping to reduce transmission, as long as the request to use their data is clear, transparent and time limited.
As the non-executive chairman of iPLATO, the developers of myGP, the free app that enables its 1.7 million NHS patient users to book appointments and access their own medical records as well as monitor and manage their own health, we regularly speak to patients about their user journey, data sharing and privacy constantly. The general consensus amongst patients when it comes to data sharing, is that if a technology acts in the interest of their health and their data is safe, they will use it - and very rarely would the developer of the app play a part in the patient’s decision-making process, further confirming that state, or tech giant - we just need a track and trace app, and quick.
About Professor Michael Lewis
Professor Michael Lewis has 30 years global health industry experience and among other roles is currently Executive Chair of iPlato, the developers of the UK’s leading medical app myGP. He is also Executive Chair of a patient mental health platform with 21 million registered users in the UK, and Chair of Cambridge Cognition plc, the neuro-psychological, diagnostics company.
Previously he held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (New Jersey), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn public to private buyout. After spending 22 of the last 26 years living and working outside the UK, Mike now works with UK based companies.
Mike also Chairs the Assisted Living Innovation Platform, is the Chair of the Biocatalyst Major Awards Panel, Chairs the KTN MedTech Board and acts as healthcare advisor for multiple private equity companies."
NHS digital have a specific remit to use information and technology to improve health and care - which the App would fall under.
I expect would be the counter argument to that.
peteblue
Welcome back Wayne
Unfortunately there is a lot of this within the Public sector Departments. Tight control over ‘their patch’ and an unwillingness or inability to look outside their domain. It happened with PPE and it happened with testing, it’s happening now with trace and test.....
- Status